Start › Rak płaskonabłonkowy głowy i szyi › Pensylwania › Philadelphia
Badania kliniczne dla Rak płaskonabłonkowy głowy i szyi w mieście Philadelphia, PA
26 badań dla Rak płaskonabłonkowy głowy i szyi szuka uczestników w ośrodkach w mieście Philadelphia i okolicach (w promieniu ok. 30 mil). Otwórz badanie, aby zobaczyć kryteria kwalifikacji i dane kontaktowe zespołu badawczego.
Oficjalny tekst badania (angielski)
Rekrutujesz uczestników do badania? Wyróżnij je na górze tej strony – $99 za 30 dni →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
RekrutacjaFaza 3
- Thomas Jefferson University Hospital, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
- Asplundh Cancer Pavilion, Willow Grove · 13 mi dalej
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekrutacjaFaza 1
- Exelixis Clinical Site #98, Philadelphia
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
RekrutacjaFaza 3
- University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RekrutacjaFaza 2
- Thomas Jefferson University Hospital, Philadelphia
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
RekrutacjaFaza 3
- University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma
RekrutacjaFaza 1
- University of Pennsylvania, Philadelphia
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
RekrutacjaFaza 2
- Thomas Jefferson University Hospital, Philadelphia
- Fox Chase Cancer Center, Philadelphia
- Jefferson Torresdale Hospital, Philadelphia
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
RekrutacjaBadanie obserwacyjne
- University of Pennsylvania, Philadelphia
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RekrutacjaFaza 2
- Fox Chase Cancer Center, Philadelphia
- Temple University Hospital, Philadelphia
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
RekrutacjaFaza 2
- Research Site, Philadelphia
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
RekrutacjaBadanie obserwacyjne
- University of Pennsylvania, Philadelphia
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
RekrutacjaFaza 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
RekrutacjaFaza 2
- Asplundh Cancer Pavilion, Willow Grove · 13 mi dalej
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
RekrutacjaFaza 1
- Normunity Investigational Site, Philadelphia
- Normunity Investigational Site, Philadelphia
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
RekrutacjaFaza 2/3
- Thomas Jefferson University Hospital, Philadelphia
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
RekrutacjaFaza 3
- Christiana Care Health System-Concord Health Center, Chadds Ford · 23 mi dalej
- Christiana Care Health System-Wilmington Hospital, Wilmington · 25 mi dalej
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RekrutacjaFaza 1/2
- University of Pennsylvania, Philadelphia
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekrutacjaFaza 1
- Perelman Center for Advanced Medicine /ID# 250188, Philadelphia
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
RekrutacjaFaza 3
- GSK Investigational Site, Philadelphia
Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
RekrutacjaFaza 1
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
Neoadjuvant CADI-05 in Combination With Pembrolizumab for Surgically Resectable Locally Advanced Head and Neck Squamous Cell Carcinomas
RekrutacjaFaza 1
- Fox Chase Cancer Center, Philadelphia
- Temple University Hospital, Philadelphia
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RekrutacjaFaza 3
- Fox Chase Cancer Center, Philadelphia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
RekrutacjaFaza 1/2
- University of Pennsylvania, Philadelphia
Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
Rekrutacja
- Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RekrutacjaFaza 1
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
- Fox Chase Cancer Center, Philadelphia
A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases
RekrutacjaFaza 3
- Thomas Jefferson University, Sidney Kimmel Cancer Center, Philadelphia
Badania dla Rak płaskonabłonkowy głowy i szyi w innych miastach
- Houston, TX47 badań
- Los Angeles, CA42 badań
- Boston, MA40 badań
- Nashville, TN39 badań
- New York City, NY39 badań
- St. Louis, MO28 badań
- Arlington, VA26 badań
- Chicago, IL26 badań
- Atlanta, GA24 badań
- San Antonio, TX22 badań
- Pittsburgh, PA22 badań
- New Haven, CT22 badań
Inne badania w mieście Philadelphia
- Nowotwory (wszystkie typy)59 badań
- Rak piersi56 badań
- Niedrobnokomórkowy rak płuca51 badań
- Nowotwór przerzutowy46 badań
- Rak prostaty44 badań
- Rak jelita grubego i odbytnicy44 badań
- Rak jajnika44 badań
- Rak płuc36 badań
- Ostra białaczka szpikowa34 badań
- Niewydolność serca31 badań
- Rak endometrium28 badań
- Depresja26 badań
Źródło: ClinicalTrials.gov, dane pobrane 6 paź 2026. Każde badanie ustala własne kryteria kwalifikacji; zespół badawczy decyduje, kto może wziąć udział.